You have 9 free searches left this month | for more free features.

influenza vaccine

Showing 1 - 25 of 9,307

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults

Recruiting
  • Influenza
  • +2 more
  • Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4)
  • High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4)
  • Oakland, California
    Kaiser Permanente Northern California (entire region)
Sep 1, 2023

Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine

Not yet recruiting
  • Influenza, Human
  • ARCT-2138
  • +2 more
  • Brisbane, Queensland, Australia
    Nucleus Network Brisbane Clinic
Nov 8, 2023

Influenza Trial in Santiago de Compostela (Influenza vaccine)

Recruiting
  • Influenza
  • Influenza vaccine
  • Santiago de Compostela, A Coruña, Spain
    General Public Health Directorate of Galician Health Service
Nov 15, 2023

Seasonal Influenza Trial in China (Quadrivalent influenza vaccine(0.25ml), Quadrivalent influenza vaccine(0.5ml), Trivalent

Not yet recruiting
  • Seasonal Influenza
  • Quadrivalent influenza vaccine(0.25ml)
  • +3 more
  • Lu'an, Anhui, China
  • +4 more
Sep 15, 2023

VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During

Not yet recruiting
  • Influenza Immunization (Healthy Volunteers)
  • Quadrivalent Influenza Vaccine
  • High-Dose Quadrivalent Influenza Vaccine
  • (no location specified)
Sep 22, 2023

Vaccination; Infection Trial (Vaccine injection)

Not yet recruiting
  • Vaccination; Infection
  • Vaccine injection
  • (no location specified)
Oct 12, 2023

Influenza, Human Trial (Quadrivalent Influenza Vaccine (split virion, inactivated), Trivalent Influenza Vaccine (split virion,

Not yet recruiting
  • Influenza, Human
  • Quadrivalent Influenza Vaccine (split virion, inactivated)
  • +2 more
  • (no location specified)
Mar 9, 2023

Quadrivalent Influenza Vaccine Immunization Schedule for

Completed
  • GCP
  • Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
  • Jinan, Shandong, China
    Kou Zengqiang
Oct 17, 2023

Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)

Not yet recruiting
  • Influenza, Human
  • sa-mRNA vaccine Dose 1
  • +4 more
  • (no location specified)
Sep 7, 2023

Immunization; Infection, Transplantation Infection, Influenza Trial in Nashville (Standard Dose Quadrivalent Inactivated

Not yet recruiting
  • Immunization; Infection
  • +2 more
  • Standard Dose Quadrivalent Inactivated Influenza Vaccine
  • High Dose Quadrivalent Inactivated Influenza Vaccine
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jul 11, 2023

Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])

Completed
  • Influenza
  • +4 more
  • Influenza vaccine [inactivated]
  • Kol'tsovo, Novosibirsk Region, Russian Federation
  • +4 more
May 11, 2023

Influenza Trial in Bangkok (TetraFluvac TF vaccine, Seasonal quadrivalent vaccine-split subunit vaccine with the strains 2023)

Not yet recruiting
  • Influenza
  • TetraFluvac TF vaccine
  • Seasonal quadrivalent vaccine-split subunit vaccine with the strains 2023
  • Bangkok, Thailand
    Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol Univ
May 30, 2023

Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention Trial in Mechelen (ExPEC9V, Placebo, HD

Recruiting
  • Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
  • ExPEC9V
  • +2 more
  • Mechelen, Belgium
    Az Sint-Maarten
Nov 13, 2023

Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])

Recruiting
  • Influenza
  • +3 more
  • Influenza vaccine [inactivated]
  • Ekaterinburg, Russian Federation
  • +6 more
Feb 13, 2023

Influenza, COVID-19, Influenza Immunogencity Trial in United States (Simultaneous Vaccination (Influenza Vaccine and mRNA COVID

Not yet recruiting
  • Influenza
  • +3 more
  • Simultaneous Vaccination (Influenza Vaccine and mRNA COVID booster)
  • +2 more
  • Phoenix, Arizona
  • +7 more
Aug 30, 2023

Influenza Trial in China (Quadrivalent Influenza Vaccine, Trivalent Influenza Vaccine 1 SP Shz TIV1, Trivalent Influenza Vaccine

Completed
  • Influenza
  • Quadrivalent Influenza Vaccine
  • +2 more
  • Kunming, China
  • +6 more
Nov 4, 2022

Influenza Trial in Brookvale (OVX836 480µg, Quadrivalent Inactivated Influenza Vaccine (Fluarix® Tetra), Placebo)

Completed
  • Influenza
  • OVX836 480µg
  • +2 more
  • Brookvale, New South Wales, Australia
    Northern Beaches Clinical Research
Dec 15, 2022

Influenza Immunization Trial (Recombinant influenza vaccine (RIV4) season/2022-2023/NH, Quadrivalent influenza vaccine (IIV4)

Not yet recruiting
  • Influenza Immunization
  • Recombinant influenza vaccine (RIV4) season/2022-2023/NH
  • Quadrivalent influenza vaccine (IIV4) season/2022-2023/NH
  • (no location specified)
Aug 23, 2022

Influenza, Behavior and Behavior Mechanisms Trial in Hellerup (Behavioral Economic Principles)

Recruiting
  • Influenza
  • Behavior and Behavior Mechanisms
  • Behavioral Economic Principles
  • Hellerup, Hovedstaden, Denmark
    Center for Translational Cardiology and Pragmatic Randomized Tri
Sep 8, 2023

Uptake of Childhood Live Attenuated Influenza Vaccine and

Completed
  • Influenza
    • London, United Kingdom
      CPRD
    Oct 4, 2023

    Influenza A, Pandemic Influenza Trial in Oslo (H7HLAII)

    Recruiting
    • Influenza A
    • Pandemic Influenza
    • H7HLAII
    • Oslo, Norway
      Oslo University Hospital
    Sep 20, 2023

    Influenza Trial in Lima (FLUAD Quadrivalent, FluQuadri)

    Active, not recruiting
    • Influenza
    • FLUAD Quadrivalent
    • FluQuadri
    • Lima, Peru
    • +1 more
    Sep 19, 2023

    Immune Response Trial in Maastricht (Influenza vaccine, Agaricus bisporus capsules, Control capsules)

    Not yet recruiting
    • Immune Response
    • Influenza vaccine
    • +2 more
    • Maastricht, Limburg, Netherlands
      Maastricht University Medical Center
    Sep 11, 2023

    Influenza Trial in Raymond Terrace (OVX836 480µg, Quadrivalent Inactivated Influenza Vaccine (Brand 1), Quadrivalent Inactivated

    Not yet recruiting
    • Influenza
    • OVX836 480µg
    • +3 more
    • Raymond Terrace, Brisbane, Australia
      Mater Misericordiae University Hospital
    Feb 9, 2023

    Patients Given Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine

    Recruiting
    • Influenza, Human
    • COVID-19
    • Comirnaty
    • Quadrivalent Influenza Vaccine
    • New York, New York
      Pfizer
    May 11, 2023